[1]姚红兵,吴爱国,黄宗海.Survivin在结直肠癌中的表达及其临床意义[J].南方医科大学学报,2004,(12):1412-1415.
 YAO Hong-bing,WU Ai-guo,HUANG Zong-hai.Expression of survivin and its clinical significance in colorectal carcinoma[J].,2004,(12):1412-1415.
点击复制

Survivin在结直肠癌中的表达及其临床意义()
分享到:

《南方医科大学学报》[ISSN:/CN:]

卷:
期数:
2004年12期
页码:
1412-1415
栏目:
出版日期:
2004-12-01

文章信息/Info

Title:
Expression of survivin and its clinical significance in colorectal carcinoma
作者:
姚红兵 吴爱国 黄宗海
南方医科大学珠江医院普通外科, 广东, 广州, 510282
Author(s):
YAO Hong-bing WU Ai-guo HUANG Zong-hai
Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China
关键词:
survivin结直肠癌组织芯片预后
Keywords:
survivingcolorectal cancertissue microarrayprognosis
分类号:
Q786;R735.37
摘要:
目的 探讨结直肠癌组织中凋亡抑制因子survivin的表达及其与各临床病理因素的关系,评价survivin在结直肠癌预后判断中的价值。方法 应用组织芯片结合免疫组织化学SABC法,检测126例早期结直肠癌组织中survivin的表达情况,回顾性分析survivin与各临床病理因素及预后之间的关系。结果 根据免疫组化染色强度和分级结果,所有病例被分为survivin高表达组和低表达组。其中高表达组有26例(26/126,20.6%),低表达组有100例(100/126,79.4%)。survivin在结直肠癌中表达情况与年龄、性别、肿瘤大小、肿瘤部位、组织学类型、浸润深度、淋巴是否转移、Dukes分期均无显著相关。然而,高表达的survivin与肿瘤复发、特别是血行转移显著相关(P<0.05)。Survivin高表达组和低表达组的生存率用Kaplan-Meier方法评估,并用log-ranktest进行比较,两组之间生存率具有显著差异(P<0.05)。多因素分析结果显示,在潜在的预后因素中(年龄、性别、肿瘤大小、肿瘤部位、组织学类型、淋巴是否转移、Dukes分期、survivin表达),survivin表达和Dukes分期被认为是结直肠癌根治术后独立预后因素。结论 Survivin的表达与结直肠癌的术后复发相关:结直肠癌术后复发率在survivin高表达组明显高于survivin低表达组,是与预后相关的独立危险因子。应用织芯片高效检测临床组织样本具有快速、方便、经济、准确的优点。
Abstract:
Objective To investigate the relationship between the expression of survivin and the clincopathological factors of colorectal carcinoma and evaluate the significance of survivin in prognotic assessment of the patients. Methods Using tissue microarray and immunohistochemical method (SABC), we examined survivin expression in 126 patients with advanced colorectal cancer and retrospectively analyzed the relationship between survivin and both the clinicopathological features and prognosis of the malignancy. Result Of the 126 patients, 26 (21%) were found to have a high survivin expression and 100 (79%) had a low expression, without relation to the patients’ age, gender, tumor size, tumor location, histological type, lymph node metastasis and Dukes’ classification. High survivin expression was strongly correlated with tumor recurrence and especially with hematogenous metastasis (P<0.05). Kaplan-Meier method and log-rank test indicated significantly different disease-free survival rates between high- and low-survivin groups (P<0.05), and Dukes’ stage and survivin expression of the tumor were identified in multivariate analysis as the independent significant factors related to disease-free survival. Conclusions Survivin expression in colorectal cancer has strong positive correlation with tumor recurrence as the independent risk factor related to prognosis. Tissue microarray enables rapid, convenient, economic and accurate large-scale examination of clinical specimens.

参考文献/References:

[1] Zhang JZ, Huang YW, Liu DM, et al. Tissue microarray technology and its preliminary application in large intestinal carcinoma [J].World Chin J Digestol, 2002, 10(2): 157-60.
[2] Ambrosini G, Adida C, Sirugo G, et al. Induction of apoptosis and inhibiton of cell profile ration by surviving gene targeting [J]. J Biol Chem, 1998, 273(18): 11177-82.
[3] Shin S, Sung BJ, Cho YS, et al. An anti-apoptotoic protein in human survivin is a direct inhibitor of caspase-3 and caspase-7 [J].Biochemistry, 2001, 40:1117-23.
[4] 徐美东.DDC基因与大肠癌研究进展[J].中国现代医学杂志,2000,10(4):30-2.Xu MD.The study development of DDC gene and colorectal cancer[J]. Chin J Modern Med, 2000, 10(4): 30-2.
[5] O’Connor DS, Schechner S, Adida C, et al. Control of apoptosis during angiogenesis by survivin expression in endothelial cells [J].Am J Pathol, 2000, 156(2): 393-8.
[6] SarelaAI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma[J]. Gut, 2000, 46: 645-50.
[7] Grossman D, Kim PJ, Schechner JS, et al. Inhibitor of melanoma tumor growth in vivo by survivin targeting [J]. Proc Natl Acad Sci USA, 2001, 98(2): 635-40.

相似文献/References:

[1]田杰,徐川,杨敏慧,等.补体应答基因-32过表达对SW480细胞骨架的影响[J].南方医科大学学报,2011,(07):1179.
[2]肖小琴,唐娜,刘超,等.结直肠癌转移相关基因PCR芯片的建立及初步应用[J].南方医科大学学报,2011,(07):1169.
[3]刘宇虎,柳娟,郭健,等.干扰素诱导的跨膜蛋白-1对诊断结直肠癌的临床价值[J].南方医科大学学报,2008,(11):1950.
[4]吴东平,贺孝文.结直肠癌中NOB1基因的表达及意义[J].南方医科大学学报,2012,(03):420.
[5]姚红兵,吴爱国,陈佑江,等.运用组织芯片技术检测COX-2在结直肠癌中的表达及其临床意义[J].南方医科大学学报,2005,(12):1524.
 YAO Hong-bing,WU Ai-guo,CHEN You-jiang,et al.Expression of COX-2 protein in colorectal carcinoma and the clinical implication[J].,2005,(12):1524.
[6]郎雁,熊永炎,陈惠桢.宫颈癌前病变和宫颈癌组织中凋亡相关基因survivin的表达及其与人乳头状瘤病毒感染的关系[J].南方医科大学学报,2005,(10):1276.
 LANG Yan,XIONG Yong-yan,CHEN Hui-zhen.Association between expression of survivin and high-risk human papillomavirus infection in cervical cancer and precancerous tissues[J].,2005,(12):1276.
[7]邓海军,孙凯,郭琛,等.人microRNA-338-3p慢病毒表达载体的构建及其靶基因鉴定[J].南方医科大学学报,2012,(08):1098.
[8]董秋美,黄赛花,黎莹,等.乳清酸磷酸核糖转移酶和结直肠癌化疗毒性的相关性[J].南方医科大学学报,2012,(08):1179.
[9]朱达坚,陈小伍,伍锦浩,等.结直肠癌围手术期替代应用肠道微生态制剂对肠道菌群及机体免疫功能的影响[J].南方医科大学学报,2012,(08):1190.
[10]梁建忠,魏宜胜,赵楚雄,等.Ⅲ期结直肠癌淋巴结转移率的预后作用[J].南方医科大学学报,2012,(11):1663.

备注/Memo

备注/Memo:
收稿日期:2004-3-19。
作者简介:姚红兵(1974- ),男,2004年毕业于南方医科大学,硕士,主治医师,电话:0773-2084040,E-mail:luckstar0503@163.com
更新日期/Last Update: 1900-01-01